rs3802971

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000612.6(IGF2):​c.*2165C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 713 hom., cov: 14)
Exomes 𝑓: 0.47 ( 323 hom. )

Consequence

IGF2
NM_000612.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0770

Publications

17 publications found
Variant links:
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGF2NM_000612.6 linkc.*2165C>T 3_prime_UTR_variant Exon 4 of 4 ENST00000416167.7 NP_000603.1 P01344-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGF2ENST00000416167.7 linkc.*2165C>T 3_prime_UTR_variant Exon 4 of 4 1 NM_000612.6 ENSP00000414497.2 P01344-1
IGF2ENST00000381406.8 linkc.*2165C>T 3_prime_UTR_variant Exon 4 of 4 2 ENSP00000370813.4 P01344-2
IGF2ENST00000381395.5 linkc.*2165C>T 3_prime_UTR_variant Exon 4 of 4 2 ENSP00000370802.1 P01344-1

Frequencies

GnomAD3 genomes
AF:
0.204
AC:
13739
AN:
67212
Hom.:
714
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.225
Gnomad AMI
AF:
0.118
Gnomad AMR
AF:
0.221
Gnomad ASJ
AF:
0.230
Gnomad EAS
AF:
0.351
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.346
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.166
Gnomad OTH
AF:
0.197
GnomAD4 exome
AF:
0.466
AC:
3827
AN:
8220
Hom.:
323
Cov.:
0
AF XY:
0.468
AC XY:
1825
AN XY:
3902
show subpopulations
African (AFR)
AF:
0.405
AC:
102
AN:
252
American (AMR)
AF:
0.390
AC:
64
AN:
164
Ashkenazi Jewish (ASJ)
AF:
0.475
AC:
230
AN:
484
East Asian (EAS)
AF:
0.558
AC:
1681
AN:
3014
South Asian (SAS)
AF:
0.455
AC:
20
AN:
44
European-Finnish (FIN)
AF:
0.500
AC:
1
AN:
2
Middle Eastern (MID)
AF:
0.525
AC:
21
AN:
40
European-Non Finnish (NFE)
AF:
0.400
AC:
1477
AN:
3690
Other (OTH)
AF:
0.436
AC:
231
AN:
530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
148
295
443
590
738
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.204
AC:
13733
AN:
67252
Hom.:
713
Cov.:
14
AF XY:
0.211
AC XY:
6785
AN XY:
32170
show subpopulations
African (AFR)
AF:
0.225
AC:
3922
AN:
17424
American (AMR)
AF:
0.220
AC:
1143
AN:
5186
Ashkenazi Jewish (ASJ)
AF:
0.230
AC:
431
AN:
1874
East Asian (EAS)
AF:
0.351
AC:
922
AN:
2628
South Asian (SAS)
AF:
0.183
AC:
332
AN:
1812
European-Finnish (FIN)
AF:
0.346
AC:
1160
AN:
3350
Middle Eastern (MID)
AF:
0.259
AC:
30
AN:
116
European-Non Finnish (NFE)
AF:
0.166
AC:
5571
AN:
33564
Other (OTH)
AF:
0.196
AC:
174
AN:
890
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
579
1158
1737
2316
2895
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0878
Hom.:
1209
Bravo
AF:
0.0951
Asia WGS
AF:
0.145
AC:
503
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
6.1
DANN
Benign
0.93
PhyloP100
-0.077
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3802971; hg19: chr11-2152052; API